相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy
Chao Chen et al.
INFLAMMATORY BOWEL DISEASES (2019)
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
William J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
William J. Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Truven Health Analytics MarketScan Databases for Clinical Research in Colon and Rectal Surgery
Audrey S. Kulaylat et al.
CLINICS IN COLON AND RECTAL SURGERY (2019)
Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention
Jean-Frederic Colombel
INFLAMMATORY BOWEL DISEASES (2018)
Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
Kevin L. Winthrop et al.
INFLAMMATORY BOWEL DISEASES (2018)
Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database
Eric M. Ammann et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Validation of a claims-based algorithm identifying eligible study subjects in the ADAPTABLE pragmatic clinical trial
Ezra Fishman et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2018)
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis
J. -F. Colombel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frederic Colombel et al.
GUT (2017)
Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis
Raymond K. Cross
INFLAMMATORY BOWEL DISEASES (2017)
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014
Eboselume Akhuemonkhan et al.
BMJ OPEN GASTROENTEROLOGY (2017)
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
Jordan E. Axelrad et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year
Peter R. Gibson et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013
Bjorn Kantso et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database
Megan E. McAuliffe et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Cancer and Immunomodulators in Inflammatory Bowel Diseases
Livia Biancone et al.
INFLAMMATORY BOWEL DISEASES (2015)
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2014)
Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program
Sarah L. Cutrona et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
Ingrid Ordas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2012)
Long-term infliximab maintenance therapy for ulcerative colitis: The ACT-1 and-2 extension studies
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2012)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
